603 related articles for article (PubMed ID: 17927887)
21. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph node biopsy in breast cancer patients: experience of a single center].
Yang B; Zheng G; Zuo WS; Yang L; Wang YS; Zheng MZ; Liu YS; Yu ZY
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):389-93. PubMed ID: 24054019
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting false-negative breast sentinel node biopsy in Chinese patients.
Chok KS; Suen DT; Lim FM; Li GK; Kwong A
ANZ J Surg; 2007 Oct; 77(10):866-9. PubMed ID: 17803550
[TBL] [Abstract][Full Text] [Related]
25. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer.
Papa MZ; Zippel D; Kaufman B; Shimon-Paluch S; Yosepovich A; Oberman B; Sadetzki S
J Surg Oncol; 2008 Nov; 98(6):403-6. PubMed ID: 18683193
[TBL] [Abstract][Full Text] [Related]
26. [Sentinel lymph node biopsy in breast cancer].
Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
[TBL] [Abstract][Full Text] [Related]
27. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
30. [Clinical significance of sentinel lymph node biopsy for breast cancer].
Zuo W; Wang Y; Li M
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):247-50. PubMed ID: 11783099
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
[TBL] [Abstract][Full Text] [Related]
32. Surmounting the challenges of sentinel lymph node biopsy for breast cancer in non-tertiary centres and community-based practices.
Tan MP
ANZ J Surg; 2006 May; 76(5):306-9. PubMed ID: 16768687
[TBL] [Abstract][Full Text] [Related]
33. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
[TBL] [Abstract][Full Text] [Related]
35. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers.
Tousimis E; Van Zee KJ; Fey JV; Hoque LW; Tan LK; Cody HS; Borgen PI; Montgomery LL
J Am Coll Surg; 2003 Oct; 197(4):529-35. PubMed ID: 14522317
[TBL] [Abstract][Full Text] [Related]
36. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
37. [Ex vitro sentinel lymph node mapping in colorectal carcinoma].
Chen DJ; Zhou FQ; Gan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):124-6. PubMed ID: 16555150
[TBL] [Abstract][Full Text] [Related]
38. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
40. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]